Clinical Trial Update: Observational Retrospective Study to Assess the Use of Ribociclib in Patients With HR+, HER2- Metastatic Breast Cancer Treated With Chemotherapy

View source ↗

Summary

A retrospective observational study evaluating the use of ribociclib in patients with HR-positive, HER2-negative metastatic breast cancer treated with chemother…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Kisqali (ribociclib) (ribociclib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Metastatic Breast Cancer | Status: COMPLETED